Abstract: A veterinary composition comprising 75-85% of an actively absorbed monosaccharide, from 3.5 to less than 5% of an actively absorbed naturally occurring amino acid, 5-10% of one or more citrate salts. The composition is useful in the treatment of diarrhoea in domestic animals such as calves.

Abstract: A composition useful in oral immunisation of animals such as poultry comprises dry free-flowing particles each consisting of a solid beadlet of lipid-continuous emulsion containing from about 25% to about 50% by weight water in a lipid, such as hardened palm kernel oil, having a slip point in the range 35.degree. to 45.degree. C., each beadlet having an average diameter of about 2 to 3 millimeters and containing at least 1 viable encysted protozoan, such as a sporulated oocyst of a species of coccidium infective to poultry, each beadlet having a protective coating of animal feed, cement and/or gypsum, the protective coating having an average thickness of about 0.2 to 2 mm.

Abstract: An oral composition containing ionizable compounds of zinc flavor-masked with anethole and prepared in the forms of pleasant tasting lozenges, soft candies, syrups, powders and chewing gums for delivery of zinc to the oral and oral pharyngeal mucosa of a human with said composition being absent the taste or aftertaste of zinc, and being primarily intended for use in treating the common cold.

Abstract: Process for preparing dog biscuits which are nutritionally balanced and which contain at least one inorganic pyrophosphate salt. The ingredients and the at least one inorganic pyrophosphate salt are selected and adjusted in amounts to provide a nutritional balance in the dog biscuit dough, from which the dog biscuits are produced. The nutritionally-balanced dog biscuits containing at least one inorganic pyrophosphate salt are chewed and/or eaten by dogs, with the result that tartar accumulations on their teeth are reduced or prevented.

Abstract: Devices, compositions and the like which have or contain at least one inorganic pyrophosphate salt. The devices or compositions are used to reduce or prevent tartar accumulations on dog teeth.

Abstract: A deodorant has the genus butyric acid bacteria and the genus Bacillus subtilis as effective components and is used for deodorizing the excrement of various animals and other sources of foul odors. The combined use of the genus butyric acid bacteria and the genus Bacillus subtilis makes it possible to deodorize the sources of foul odors by decomposing hydrogen sulfide, ammonia, mercaptan, etc., contained in the sources of the foul odors.

Abstract: This invention relates to a carrier for the transport of drugs in a mammalian system comprising milk fat globules.

Abstract: A method and composition for the inhibition of growth of Salmonella is provided. The effective composition of the invention is a composition which is fermented by microflora other than Salmonella at a rate competitively greater Salmonella or which is fermented by microflora other than Salmonella to produce metabolites which inhibit the growth of Salmonella. In one embodiment of the prevent invention, the effective composition is a class of fructo-oligosaccharides which inhibit the growth of Salmonella. More particularly, the fructo-oligosaccharides are sucrose molecules having from 1 to 8 fructose residues. This class of sugars is exemplified by "Neosugar" which includes 1-kestose, nystose, and 1-fructofuranosyl-nystose. The present method includes containing Salmonella with the effective composition and can include feeding it to a domestic food animal. The present composition includes the effective component and nutritive feed material.

Abstract: DL-methionine is fed to a ruminant animal in slow release form so as to stimulate protein growth in the first stomach or rumen and thus control growth of the animal.

Abstract: Active ingredients useful in chewable articles of commerce are physically encased in non-porous, chewable, particles of elastomer and such particles are then incorporated in the articles of commerce. During mastication of the chewable article of commerce the active ingredient is released from the elastomer particles over a prolonged period of time. The active ingredients would include flavorants, intense sweeteners, colorants, medicaments, effervescent agents and tobacco.

Abstract: A method for reducing stress in animals, such as pigs in an overcrowded breeder, by exposing a block to be licked by the animals. The block contains at least 50% by weight and preferably at least 70% by weight glucose, has a compressive strength over 5 kg/cm.sup.2 preferably 50-150 kg/cm.sup.2, and a water contentof 0.1-20% by weight. The block is too large to be swallowed by the animals and its compressive strength prevents crumbling. It is at least 50 g in weight, e.g. 500 g, and each dimension is more than 2 cm. The block is preferably secured above ground level and is slowly consumed by the animals by licking or pecking.

Abstract: This invention discloses and claims improved methods to reduce duration of common colds in humans through use of pharmaceutically acceptable zinc compounds topically and frequently applied to the oral mucosa by various means. The invention improves upon the prior art using zinc gluconate throat lozenges to reduce the duration of common colds and zinc borate intranasally as an astringent and decongestant in treatment of common colds.

Abstract: A granular composition for a ruminant containing as a main component choline or a physiologically acceptable derivative thereof, wherein the composition is prepared by (1) granulating the choline or it derivative having an average particle size of 100 .mu.m or less and a maximum particle size of 150 .mu.m or less, an excipient having an average particle size of 10 .mu.m or less and a maximum particle size of 20 .mu.m or less, and a hydrophobic binder under a relative humidity of 10% or less by using an agitation granulator, followed by cooling, separating and classifying the resultant granules to obtain spherical granules having a particle size of 0.5 to 2.5 mm and (ii) forming a thin film on the surface of the granules at a temperature of at least 5.degree. C. less than a melting point of the binder and 5.degree. C. to 25.degree. C.

Abstract: Disclosed is a method for improving the feed conversion efficiency of meat-producing animals by oral administration of an effective amount of 2-deoxy-D-hexose such as 2-deoxy-D-glucose. Also disclosed are animal feed compositions comprising standard animal feed in admixture with 2-deoxy-D-hexose.

Abstract: The present invention relates to a method and composition for increasing the breast weight to body weight ratio in poultry. The present invention also relates to methods and compositions for reducing mortality and reducing the occurrence of air sac lesions in poultry and livestock. The compositions of the present invention include fructooligosaccharides, and in particular, fructooligosaccharides produced by the action of a fructosyl transferase enzyme on a sucrose substrate. The methods of the present invention involve the administration of compositions including fructooligosaccharides to poultry and livestock. The fructooligosaccharides are preferably administered by incorporation into the poultry or livestock's food supply.

Abstract: By giving mammals, fowls, fish, etc. feeds containing Bacillus subtilis C-3102 (FERM BP-1096), an excellent body weight gain and feed efficiency can be obtained.

Abstract: The antibiotic of the formula: ##STR1## wherein R is ##STR2## The antibiotic is useful for the treatment of swine dysentery and for promoting growth and/or increasing the efficiency of food utilization in poultry, swine and ruminants.

Abstract: A method for improving the growth rate, feed conversion efficiency and/or the ratio of carcass lean to carcass fat of domestic animals comprising the administration to said animals of salbutamol or an acid addition salt thereof in combination with an antimicrobial agent.

Abstract: The compounds: ##STR1## in which the dotted line represents optional unsaturation; R.sup.1 is hydrogen, halo or alkoxy; R.sup.2 is hydrogen or alkoxy and X is methylene, ethylene, ethylidene, 1,2-propylene or propylene; or a biologically acceptable salt thereof are growth promoting agents which rapidly lead to increased lean body mass in domestic animals and humans.

Abstract: A method and composition for the inhibition of growth of Salmonella is provided. The effective composition of the invention is a class of fructo-oligosaccharides which inhibit the growth of Salmonella. More particularly, the fructo-oligosaccharides are sucrose molecules having from 1 to 8 fructose residues. This class of sugars is exemplified by "Neosugar" which includes 1-kestose, nystose, and 1-fructofuranosylnystose. The present method includes contacting Salmonella with the effective composition and can include feeding it to a domestic food animal. The present composition includes the effective component and nutritive feed material.

Abstract: This invention discloses processes and resulting products for the manufacture of metal heptonates from saccharides via a Kiliani-Fisher reaction and subsequent reaction with the desired metal. Manganese, iron, copper zinc and magnesium heptonates are each made by a slightly different process but the resulting metal chelates provide a soluble form of the metal for agricultural, industrial, environmental and construction uses. The amount of metal chelated is directly related to the percentage of fructose in the initial monosaccharide mixture. For cations with no color, the chelating agent can be decolorized with H.sub.2 O.sub.2 to give a lighter colored product providing the NH.sub.3 concentration is reduced below 0.35% prior to the decolorizing step. An equivalent strong oxidizing agent may be used instead of H.sub.2 O.sub.2.

Abstract: A food supplement composition is described containing an oat extract and an extract of nettle (Urtica). The combined extracts can be in the form of powder which is added to a beverage or any fruit juice to provide a nutritional drink. The composition can also be used for the treatment of a dysfunction of a warm blooded mammal. The products can be taken in various forms such as dried powdered mix with a liquid, as a pill, tablet, capsule, or for nasal delivery.

Abstract: A method, and compositions, for use in the prevention and treatment of fescue toxicosis in animals, especially cattle, sheep and horses, comprising administering to the animals a dopamine antagonist which does not cause adverse psychological or neurological effects. Useful dopamine antagonists are those specific for D.sub.2 receptors including metoclopramide, sulpiride, tiapride, alizapride and other substituted benzamides. The preferred compound is metoclopramide, a substituted benzamide having the formula 4-amino-5 chloro-N-[2-(diethylamino)ethyl]-2-methoxy benzamide monohydrochloride monohydrate. The correct dosage can be determined from the combination of the behavioral response of the animal to the compound and by measuring the serum prolactin levels over time.In the preferred method, the compound is administered to the animals orally, using capsules, timed or slow release boluses, or as an additive in a salt, mineral, protein or energy block or animal feed, or as an implant.

Abstract: A stock feed containing a specific amount of galacto-oligosaccharides, the stock feed being effective in the prevention of scours/loose passage of livestocks and thus in the increase of their weight.

Abstract: A method for reducing stress in animals, such as pigs in an overcrowded breeder, by exposing a block to be licked by the animals. The block contains at least 50% by weight and preferably at least 70% by weight glucose, has a compressive strength over 5 kg/cm.sup.2 preferably 50-150 kg/ cm.sup.2, and a water content of 0.1-20% by weight. The block is too large to be swallowed by the animals and its compressive strength prevents crumbling. It is at least 50 g in weight, e.g. 500 g, and each dimension is more than 2 cm. The block is preferably secured above ground level and is slowly consumed by the animals by licking or pecking.

Abstract: A prefabricated animal bait containing a carrier substance and a pharmaceutically active substance, for example, a vaccine against rabies. The carrier substance contains a fat component and an additive to stabilize the shape retention of the bait, with both components being selected in such a manner that the mixture is pasty for processing and does not break in the temperature range in which it will be used. The bait is produced in such a manner that, in a deep-drawn mold, the carrier substance completely surrounds, and envelopes a pre-assembled unit of the active substance so that the bait merely needs to be pressed out of this carrier foil when it is to be used. Economical industrial production of prefabricated bait in a simple manner, easily and optimally adaptable to the respective animal species and its habitat with respect to temperature and moisture is provided. A particular simlification results from the use of fish meal as the additive since it simultaneously acts as a lure.

Abstract: A composition for synergistically increasing milk fat production in ruminants comprising (1) pellets which comprise an antacid selected from the group consisting of sodium and magnesium antacids and an electrolyte selected from the group consisting of potassium, sodium, and chlorine containing electrolytes, said pellets containing potassium, sodium, and chlorine in a weight ratio of from about 1.5 to about 1.8 parts of potassium and from about 1.2 to about 1.5 parts of chlorine per part of sodium, said potassium being present in sufficient amount to provide from about 0.8 to about 1 weight parts of potassium per weight part of any magnesium present and (2) sodium bicarbonate.

Abstract: An animal food product for administering medication to animals is a formed, chewable food treat with at least one pre-formed pocket therein opening to an outer surface of the treat and sized to retain a medicant therein.

Abstract: The Resorcylic Acid Lactone (RAL) derivatives zearalenone, zearalanone, zearalene, zearalane, zearalenol, zearalanol, and dideoxyzearalane are administered to vertebrates to non-specifically stimulate the immune system.

Abstract: A dietary supplement formulated to suppress appetite comprising L-phenylalanine in combination with restricted quantities of protein, carbohydrate, fat and dietary fiber.

Abstract: A post-rumen effective composition for oral administration to ruminants containing a bioactive substance molecularly dispersed with a basic polymer. The bioactive substance is miscible with the polymer and may be a vitamin, antibiotic, peptide or anti-inflammatory agent. The basic polymer contains from about 1 percent to about 25 percent by weight of nitrogen and is resistant to a pH of greater than about 5 and soluble or swellable at a pH of less than about 3.5.

Abstract: Disclosed herein is a granule containing physiologically-active substance which comprises at least(A): a physiologically-active substance;(B): a substance which is stable under neutral condition but disintegrates or dissolves at a pH of 3 or less; and(C): at least one substance selected from the group consisting of straight-chain or branched, saturated or unsaturated monocarboxylic acids having at least 14 carbon atoms and salts thereof, animal fats having a melting point of 40.degree. C. or higher, vegetable fats having a melting point of 40.degree. C. or higher and waxes having a melting point of 40.degree. C. or higher, and which granule further has a protective film comprising at least said substances (B) and (C) on the surface thereof. The protective film has a thickness of preferably at most 20% of the granular diameter and is preferably at least composed of at least 10% by weight of the substance (B) and at most 90% by weight of the substance (C).

Abstract: Novel articles are prepared by forming or shaping protein/polymeric material blends. The resulting articles are attractive to masticating animals. Uses for such as synthetic bones and as a bait or lure are disclosed. Novel compositions as well as method for making the novel articles of the invention are also disclosed.

Abstract: The invention disclosed and claimed is a method to reduce duration of common colds in humans as evinced by reduction of duration of 10 common cold symptoms through use of zinc gluconate topically and frequently applied to the oral mucosa. The invention improves upon the prior art using zinc intranasally as an astringent and decongestant in treatment of common colds. Results of a clinical study are presented in support of disclosure and claims.